Explaining the New COVID-19 Vaccination Requirement for Health Care Provider Staff
This issue brief examines the new regulations, explains the status of the pending litigation, and identifies issues to watch.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This issue brief examines the new regulations, explains the status of the pending litigation, and identifies issues to watch.
This brief describes the characteristics of fully vaccinated hospitalized patients who have COVID-19 breakthrough infections, in comparison to people who are not fully vaccinated and hospitalized with COVID-19.
“Breakthrough” hospitalizations involving COVID-19 among people who are fully vaccinated against the disease most often affected older adults and people with other chronic health conditions, finds a new analysis of hospital data from June through September by KFF and Epic Research. More than two-thirds (69%) of breakthrough COVID-19 hospitalizations occurred among people ages 65 and older, who are more likely than younger age groups to have gotten vaccinated. A fifth (21%) of breakthrough hospitalizations occurred…
COVID-19 vaccine uptake among adolescents ages 12-17 has slowed after an initial wave of enthusiasm over the summer, with half (49%) of parents saying their adolescent has received at least one dose, a new KFF COVID-19 Vaccine Monitor report reveals. The share is little changed since earlier in the fall. Just 1% of parents of adolescents now say they will get their adolescent vaccinated as soon as possible, and 13% say they want to wait…
This report updates parents' intentions for vaccinating their children, against COVID-19, as well as their views and concerns about vaccine safety, whether their schools encourage vaccination, and how the pandemic has affected their children, mental health, and ability to afford necessities.
As of December 5, 16.7% of 5-11 year-olds had received at least one COVID-19 vaccine dose with 4.3% of children reaching full vaccination, according to a new KFF analysis. After a short period of high demand, the rate of new vaccinations slowed significantly leading into the Thanksgiving holiday and has continued at the slower pace since. Vaccination efforts around the country continue to differ, with more than a 40 percentage point difference between the top…
This report shows an increasing share of the public are frustrated about the status of COVID-19 vaccinations in the U.S.. The share of fully vaccinated adults who report receiving a booster dose has more than doubled in the last month, though vaccine uptake overall is little changed. The poll also explores attitudes towards federal mandates on workplace vaccinations and the pandemic's toll on different groups.
Public is Less Optimistic and More Frustrated with State of Vaccinations Now Than in January Nearly a quarter (23%) of fully vaccinated adults have already received a COVID-19 booster shot, more than double the share who had done so in October (10%), the latest KFF COVID-19 Vaccine Monitor report reveals. Most other vaccinated adults say they definitely (37%) or probably (19%) will get a booster shot as recommended, while about a fifth say they will…
As states expand COVID-19 vaccination efforts to reach newly eligible children ages 5 to 11, a new KFF analysis highlights several tools state Medicaid programs have at their disposal to increase access to, and take up of, vaccines among lower-income children. Among the key findings: States can request Medicaid administrative federal matching funds for state-funded monetary incentives to encourage uptake of the vaccine. In recent months, several states reported activities and incentives within contracted Medicaid…
Following the recent US Food & Drug Administration’s (FDA) authorization and the Centers for Disease Control and Prevention’s (CDC) recommendation, children ages 5-11 are now eligible to receive Pfizer-BioNTech’s COVID-19 vaccine. There may be unique challenges to vaccinating young children, particularly those from low-income families who may face additional barriers to access. State Medicaid programs and Medicaid managed care plans are looking at a range of policy options to facilitate access to vaccines for young,…
© 2026 KFF